Now Viewing Articles

Media and Related Feeds

Dec 12, 2016

Benchside Dispatches: An interview with Angela Christiano, PhD

By: Advancing Innovation in Dermatology

Epidermolysis bullosa: An interview with Angela Christiano, PhD

Welcome to the fifth installment of Benchside Dispatches. In this installment, Angela Christiano, PhD, discusses epider molysis bullosa (EB). Dr. Christiano is the Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics & Development and Director, Basic Science Research Group of Dermatology at Columbia University College of Physicians & Surgeons.

Her research focus is the study of inherited diseases of skin and hair, and a major objective of her laboratory is to develop innovative therapies through an advanced molecular understanding of disease pathogenesis. Dr. Christiano has published extensively in the peer-reviewed literature, and her breakthrough work in EB can be found in journals including Science Translational Medicine, Nature Genetics, the Journal of Clinical Investigation, PNAS, and the Journal of Investigative Dermatology. She is on the board of trustees and scientific advisory board of DEBRA of America, and is the current President of the Society for Investigative Dermatology.

Epidermolysis bullosa is a family of rare skin blistering conditions that currently have no cure. EB can have devastating and even life-threatening sequelae, including the development of cutaneous squamous cell cancer associated with the most severe forms of dystrophic EB. Those that live with the condition can continually experience great discomfort and negative quality of life, as the current treatments are palliative in nature.

Read the full article: Download PDF